Affinity Asset Advisors »

Absci Corp shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Absci Corp (ABSI) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Absci Corp

Tip: Access up to 7 years of quarterly data

All positions including Absci Corp held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Absci Corp by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.8M 1.0M 5.68

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Moderna Put Option (MRNA)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Arcellx Common Stock (ACLX)
Vera Therapeutics Cl A (VERA)
Inozyme Pharma (INZY)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Kura Oncology (KURA)
Spyre Therapeutics Com New (SYRE)

View all positions for Affinity Asset Advisors

Top funds holding Absci Corp

FMR
Redmile Group
Fred Alger Management
Vanguard Group
ARK Investment Management
Millennium Management
Marshall Wace
Woodline Partners
Laurion Capital Management
Affinity Asset Advisors
Casdin Capital
Susquehanna International
BlackRock
Platinum Investment Mangement
Qube Research & Technologies

View all funds holding Absci Corp